S. Mawdsley

480 total citations
16 papers, 337 citations indexed

About

S. Mawdsley is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, S. Mawdsley has authored 16 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in S. Mawdsley's work include Colorectal and Anal Carcinomas (8 papers), Colorectal Cancer Treatments and Studies (4 papers) and Colorectal Cancer Surgical Treatments (3 papers). S. Mawdsley is often cited by papers focused on Colorectal and Anal Carcinomas (8 papers), Colorectal Cancer Treatments and Studies (4 papers) and Colorectal Cancer Surgical Treatments (3 papers). S. Mawdsley collaborates with scholars based in United Kingdom, United States and Australia. S. Mawdsley's co-authors include Rob Glynne‐Jones, R. Glynne‐Jones, J R Novell, Tillman Pearce, Marc Buyse, Peter Cole, Paul Cullinan, Kathryn Nash, Pallav L. Shah and Mark Harrison and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

S. Mawdsley

12 papers receiving 334 citations

Peers

Countries citing papers authored by S. Mawdsley

Since Specialization

Citations

This map shows the geographic impact of S. Mawdsley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Mawdsley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Mawdsley more than expected).

Fields of papers citing papers by S. Mawdsley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Mawdsley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Mawdsley. The network helps show where S. Mawdsley may publish in the future.

Co-authorship network of co-authors of S. Mawdsley

This figure shows the co-authorship network connecting the top 25 collaborators of S. Mawdsley. A scholar is included among the top collaborators of S. Mawdsley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Mawdsley. S. Mawdsley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	85 Assessing tolerability and toxicity of adjuvant Osimertinib following tumour resection of early-stage EGFR-mutated non-small cell lung cancer through real-world data 2024 ·Lung Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Andreas Polychronis, Γεώργιος Αντωνίου, (unknown), Arshi Denton, S. Mawdsley, Jeanette Dickson, (unknown), Suraiya Dubash	0
2	63 Real-world outcomes of Nivlolumab-Ipilimumab combination therapy in unresectable malignant mesothelioma: Mount Vernon Cancer Centre Experience 2024 ·Lung Cancer ·(unknown), (unknown), (unknown), Thalia Afxentiou, (unknown), (unknown), (unknown), Andreas Polychronis, (unknown), (unknown), Arshi Denton, S. Mawdsley, Jeanette Dickson, (unknown), Suraiya Dubash	0
3	93 Evaluating real-world tepotinib-related toxicity data across five UK cancer units- A case-series 2024 ·Lung Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Andreas Polychronis, Γεώργιος Αντωνίου, (unknown), S. Mawdsley, Jeanette Dickson, (unknown), Suraiya Dubash	0
4	13: Case and literature review of pemetrexed induced pneumonitis 2015 ·Lung Cancer ·Indrani Bhattacharya, S. Mawdsley	0
5	Squamous cell carcinoma antigen 2013 ·Cancer ·Matthew Williams, Angela Swampillai, M. Osborne, S. Mawdsley, Rob Hughes, Mark Harrison, Richard J. Harvey, Rob Glynne‐Jones, (unknown)	26
6	PO-0792 THE DEVELOPMENT OF A CONFORMAL RADIOTHERAPY PROTOCOL FOR THE PHASE III ARISTOTLE RECTAL CANCER TRIAL 2012 ·Radiotherapy and Oncology ·R. Glynne‐Jones, (unknown), Simon Gollins, (unknown), (unknown), Samarjit Singh Ghuman, Rob Hughes, S. Mawdsley, (unknown), David Sebag‐Montefiore	1
7	A single-center study of the utility of squamous cell carcinoma antigen (SCCAg) levels in epidermoid carcinoma of the anal canal and margin (ECACM) treated with chemoradiation (CRT) 2009 ·Journal of Clinical Oncology ·Angela Swampillai, Myia S. Williams, M. Osborne, S. Mawdsley, Rob Hughes, Mark Harrison, Rob Glynne‐Jones	1
8	Anal cancer: is neoadjuvant cisplatin chemotherapy or chemoradiotherapy friend or foe? 2008 ·Nature Clinical Practice Oncology ·Rob Glynne‐Jones, S. Mawdsley	2
9	The clinical significance of the circumferential resection margin following preoperative pelvic chemo‐radiotherapy in rectal cancer: why we need a common language 2006 ·Colorectal Disease ·R. Glynne‐Jones, S. Mawdsley, J R Novell	69
10	Alternative clinical end points in rectal cancer—are we getting closer? 2006 ·Annals of Oncology ·Rob Glynne‐Jones, S. Mawdsley, Tillman Pearce, Marc Buyse	75
11	Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival? 2005 ·International Journal of Radiation OncologyBiologyPhysics ·S. Mawdsley, Rob Glynne‐Jones, J. Grainger, Paul Richman, Andreas Makris, Mark Harrison, Richard Ashford, R. A. Harrison, M. Osborne, (unknown), (unknown), Ian C. Mitchell, (unknown), John Northover, Alastair Windsor, Richard Novell, Marina Wallace	81
12	The role of EGFR in predicting clinical outcome in locally advanced rectal carcinoma treated with neoadjuvant chemoradiation 2004 ·Journal of Clinical Oncology ·S. Mawdsley, Søren M. Bentzen, George D. Wilson, R. Glynne‐Jones, Frances Daley	1
13	The role of EGFR in predicting clinical outcome in locally advanced rectal carcinoma treated with neoadjuvant chemoradiation 2004 ·Journal of Clinical Oncology ·S. Mawdsley, Søren M. Bentzen, George D. Wilson, R. Glynne‐Jones, Frances Daley	1
14	Locally Advanced Pancreatic Cancer Treated with Radiation and 5-Fluorouracil 2002 ·Clinical Oncology ·S. Mawdsley, Marcia Hall, Rob Glynne‐Jones	14
15	Determinants of chronic infection with Staphylococcus aureus in patients with bronchiectasis 1999 ·European Respiratory Journal ·Pallav L. Shah, S. Mawdsley, Kathryn Nash, Paul Cullinan, Peter Cole, (unknown)	51
16	Death due to thyroid metastases from renal cell carcinoma 1998 ·Clinical Oncology ·Roger Brown, S. Mawdsley, Gillian Duchesne	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact